Monday, September 15th, 2025

Acma Ltd Auditors Issue Qualified Opinion on FY2024 Financial Statements

Financial Analysis Report: ACMA LTD (Net Profit Growth/Decline Not Specified)
Company Overview
ACMA LTD is a company with a diversified business operation. The company’s core business operations, business segments, and geographic footprint are not explicitly stated in the report. However, it is mentioned that the company has subsidiaries, indicating a possible diversified business operation.
Industry Position and Competitors
The report does not provide information on the company’s position within the industry, its competitors, and its market share.
Revenue Streams, Customer Base, Supply Chain, and Competitive Advantage
The report does not provide detailed information on the company’s revenue streams, customer base, supply chain, and competitive advantage.
Financial Statement Analysis
Income Statement
The company reported a profit for the year from discontinued operations, net of taxation, of S$1,455,000.
The company’s subsidiary, Acot Plastic (Xiamen) Co., Ltd. (APX), contributed a profit of S$4,763,000, including a gain on disposal of S$3,203,000.
The company’s subsidiary, Acot Tooling (Xiamen) Co., Ltd. (ATX), reported a loss of S$3,308,000, including a net loss on deconsolidation of S$3,123,000.
Balance Sheet and Cash Flow Statement
The report does not provide detailed information on the company’s Balance Sheet and Cash Flow Statement.
Key Facts and Investor Action
The company’s independent auditor, Forvis Mazars LLP, issued a qualified opinion on the company’s consolidated financial statements for the financial year ended 31 December 2024.
The qualified opinion is due to the company’s disposal of its entire equity interest in APX and the liquidation of ATX.
The company’s Board of Directors believes that sufficient information has been disclosed for trading of the company’s securities to continue in an orderly manner.
Dividend and Earnings
No dividend information is provided in the report.
The report does not specify the earnings increase or decrease.
Special Activity or Action
The company disposed of its entire equity interest in APX on 31 May 2024.
ATX was placed under liquidation by order of the Xiamen court on 9 May 2024.
Report Details
Date of the report: 14 April 2025
Financial year reported: 31 December 2024
Conclusion and Recommendation
Based on the report, we recommend that investors exercise caution when dealing with ACMA LTD’s stock. The qualified opinion from the auditor and the disposal of subsidiaries may indicate potential risks and uncertainties.
For current investors: We recommend holding the stock, but closely monitoring the company’s future performance and announcements.
For potential investors: We recommend caution and thoroughly researching the company’s future prospects and financials before making an investment decision.
Disclaimer: This recommendation is based solely on the information provided in the report and should not be considered as investment advice. Investors should conduct their own research and consult with financial experts before making any investment decisions.

View Acma Historical chart here



United SSE 50 China ETF: Navigating Market Volatility with Dividend and AI Strategies – FY June 2024 Report

Key Facts from the United SSE 50 China ETF Financial Report for FY Ending June 30, 2024 Financial Performance Fund NAV: The net asset value (NAV) of the United SSE 50 China ETF fell...

Hyphens Pharma Defies Odds: 32.6% Profit Surge Despite Challenging Quarter

Hyphens Pharma Posts Strong Revenue Growth in 9M2024 Despite Rising Costs Hyphens Pharma Posts Strong Revenue Growth in 9M2024 Despite Rising Costs Hyphens Pharma International Limited, along with its subsidiaries, has reported an impressive...

AsiaMedic Limited 1H2025 Financial Results: 26% Revenue Growth, Net Loss, and No Interim Dividend Declared

AsiaMedic Limited 1H2025 Financial Analysis: Ramp-Up Expansion and Profitability Headwinds AsiaMedic Limited, a Catalist-listed healthcare provider in Singapore, released its unaudited consolidated financial statements for the six months ended 30 June 2025. The report...